Zenas Biopharma Inc (ZBIO)

Finanzdaten der Zenas Biopharma Inc-Aktie (ZBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.00	-	-	-	-
	40.48%108.66	77.35	237.98	52.58	55.16
Research and Development	4.09%62.91	60.44	55.72	34.40	43.03
Operating Income/Loss	39.18%-107.66	-77.35	-237.98	-52.58	-55.16
Nonoperating Income/Loss	1.26%-3.68	-3.64	-2.35	1.08	2.96
Income/Loss From Continuing Operations Before Tax	37.48%-111.34	-80.99	-240.34	-51.50	-52.20
Income Tax Expense/Benefit	0.11	-	0.11	-	0.02
	37.62%-111.46	-80.99	-240.44	-51.50	-52.22
Attributable To Parent	37.62%-111.46	-80.99	-240.44	-51.50	-52.22
Basic Average Shares	13.46%63.11	55.62	-	42.16	41.87
Diluted Average Shares	13.46%63.11	55.62	-	42.16	41.87
Basic Earnings Per Share	21.23%-1.77	-1.46	-	-1.22	-1.25
Diluted Earnings Per Share	21.23%-1.77	-1.46	-	-1.22	-1.25